AI주식인사이트AI Stock Insight
B

모아라이프플러스

142760KOSDAQ자연과학 및 공학 연구개발업

59.6 / 100

Reference Date: 2026-06-10

Financial Score22.5 / 40
News Sentiment19.1 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Declined 13.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Moalifeplus focuses on biopharmaceutical R&D using proprietary technologies (HumaMAX, MucoMAX), alongside consumer businesses such as health functional foods, cosmetics, and pet care products. Its γ-PGA-based functional ingredients are approved by the Korean FDA and the U.S. FDA, enabling global expansion through partnerships with Swiss companies and overseas exports of skincare brands.

Number of Employees

54people

Average Salary

39.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 62.704.0Point
PBR
0.94Industry Average 3.247.0Point

Half of industry avg (excellent)

ROE
-36.73Industry Average -32.093.5Point

In line with industry avg

Debt Ratio
1.91Industry Average 7.318.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼12.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.1% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 76.2

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 681Won52-week high 2,19052-week low 622
1-month return1.0Point

1m -13.14% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-06-01
  • Neutral주식병합결정2026-06-01
  • Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-05-29
  • Neutral주주총회소집결의 (임시주주총회)2026-05-18
  • Neutral주주명부폐쇄기간또는기준일설정2026-05-18